Canyon Labs — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Canyon Labs is a rapidly growing, private contract research organization (CRO) specializing in testing and consulting services for medical device and pharmaceutical companies. Through strategic acquisitions and organic growth, it has built a national footprint with state-of-the-art facilities in Utah, New York, and California, positioning itself as a 'one-stop-shop' for critical compliance testing. The company differentiates itself through a strong focus on customer service, transparent pricing, and industry-best turnaround times, aiming to de-risk and accelerate its clients' path to market. Its business model is purely service-based, generating revenue from testing projects and consulting engagements.

Drug DeliverySmall Molecules

Technology Platform

Integrated network of ISO 17025 accredited laboratories with specialized assets including AAALAC-accredited vivarium (Rochester) and a Thermal Solutions Center of Excellence (San Diego). Capabilities span analytical chemistry, microbiology, biocompatibility/toxicology, and packaging testing for medical device and pharmaceutical compliance.

Opportunities

The growing outsourcing trend in medtech/pharma and increasing regulatory complexity for devices and temperature-sensitive biologics drive demand for its full-service testing model.

Strategic acquisitions have given it unique, hard-to-replicate assets (vivarium, thermal center) and national scale, allowing it to capture more client spend and serve a broader geographic market.

Risk Factors

Revenue is tied to client R&D cycles and could be impacted by an economic downturn.

The company faces significant integration risks from its recent acquisitions, and any failure to maintain its critical laboratory accreditations would severely damage its reputation and regulatory standing.

Competitive Landscape

Competes with large global CROs (e.g., Eurofins, Charles River Labs), numerous niche specialty testing labs, and the in-house capabilities of large manufacturers. Differentiates through a focused 'one-stop-shop' model for medical devices/pharma, emphasis on customer service and turnaround time, and unique in-house assets like an AAALAC vivarium.

More companies in Diagnostics & Precision Medicine →More companies in United States →